GlaxoSmithKline (GSK) Stock Forecast for 2025, 2026, 2027. Sell or Buy Prediction







Understanding Accounting and Bookkeeping Services for Business Success

June 10, 2025 Understanding Accounting and Bookkeeping Services for Business Success

Every successful business relies on accurate financial records. From managing cash flow to ensuring compliance with tax regulations, reliable accounting and bookkeeping services…
How much does a Turkish passport cost?

May 27, 2025 How much does a Turkish passport cost?

Turkish citizenship comes with numerous benefits. Once granted, a foreigner can enter 126 countries visa-free, enjoy high-quality healthcare and favorable tax regimes, and…
How Measurement and Mix Modeling Drive Better Business Decisions

May 22, 2025 How Measurement and Mix Modeling Drive Better Business Decisions

In today’s data-driven business landscape, the ability to accurately measure and optimize marketing efforts has become a critical competitive advantage. As marketing evolves,…
Are you making these mistakes when analyzing candlestick patterns?

May 22, 2025 Are you making these mistakes when analyzing candlestick patterns?

Trading is a very popular endeavor these days, and for good reason, as it is widely accessible and allows individuals to generate additional…
Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency

April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency

What defines a successful crypto expert? The amount of money earned, the number of luxury cars and international real estate? The presence of…

GlaxoSmithKline (GSK) Stock Forecast for 2025, 2026, 2027. Sell or Buy?

Updated: June 15, 2025 (20:14)

Sector: Healthcare

The share price of GlaxoSmithKline plc (GSK) now

Latest session on the 13th of June for
GlaxoSmithKline plc is negative
Trading Volume: 7658807
Open: 41.62 /  High: 41.93 /  Low: 40.81
Current value: $40.86
What analysts predict: $41.54
52-week High/Low: $43.19 / $31.01
50-Day Moving Average: $37.55 — support level today
200-Day Moving Average: $37.55 — support level today

Are you interested in GlaxoSmithKline plc stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the GlaxoSmithKline stock price in 2025, 2026, 2027. How much will one GlaxoSmithKline share be worth in 2025 - 2027?

When should I take profit in GlaxoSmithKline stock? When should I record a loss on GlaxoSmithKline stock? What are analysts' forecasts for GlaxoSmithKline stock? What is the future of GlaxoSmithKline stock? We forecast GlaxoSmithKline stock performance using neural networks based on historical data on GlaxoSmithKline stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

GlaxoSmithKline stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for GlaxoSmithKline shares. This happens once a day.


Historical and forecast chart of GlaxoSmithKline stock

The chart below shows the historical price of GlaxoSmithKline stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the GlaxoSmithKline stock price can be found in the table below.

Long-term forecasts by years.

GlaxoSmithKline plc is engaged in the creation, discovery, development, manufacture and marketing of pharmaceuticals, vaccines, OTC drugs and health-related consumer products in the United Kingdom, the United States and internationally. It operates in four segments: pharmaceuticals, pharmaceutical research and development, vaccines and consumer healthcare. The company offers pharmaceutical products that include drugs in therapeutic areas such as respiratory, HIV, immunoinflammatory, cancer, antiviral, central nervous system, cardiovascular and urogenital, metabolic, antibacterial and dermatological. It also provides consumer healthcare products in the categories of health, oral health, nutrition, and skin health. The company offers its consumers medical products in the form of nasal sprays, tablets, syrups, lozenges, chewing gums and transdermal patches, drops, drops of baby syrup, liquid suspension, wipes, gels, effervescent substances, toothpastes, toothbrushes, mouth rinses, adhesives for dentures and detergents, topical creams and non-drug plasters, lip balms, chewing gums and soft chewing gums. She has cooperation agreements with 23andMe; Merck KGaA; Lyell Immunopharma; CEPI; Innovax and Xiamen University; VBI; Viome; Sanofi SA; CureVac; and research collaboration with Sengenics specializing in immunology. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, UK.

Trending Themes in the Healthcare Sector

GlaxoSmithKline daily forecast for a month

Date Target Pes. Opt. Vol., %
Jun 17 41.38 41.20 41.47 0.66
Jun 18 41.50 41.18 41.67 1.19
Jun 19 41.22 41.09 41.52 1.05
Jun 20 41.40 41.20 41.61 0.99
Jun 21 41.24 41.09 41.52 1.04
Jun 22 41.42 41.14 41.54 0.98
Jun 23 41.30 41.05 41.61 1.36
Jun 24 41.23 40.91 41.33 1.03
Jun 25 41.29 40.96 41.47 1.25
Jun 26 41.44 41.31 41.70 0.94
Jun 27 41.52 41.21 41.67 1.12
Jun 28 41.61 41.41 41.84 1.04
Jun 29 41.92 41.61 42.02 0.99
Jun 30 42.15 41.82 42.25 1.01
Jul 01 42.28 42.02 42.50 1.16
Jul 02 42.34 42.05 42.60 1.30
Jul 03 42.34 42.11 42.66 1.29
Jul 04 42.53 42.44 42.86 1.00
Jul 05 42.38 42.21 42.50 0.70
Jul 06 42.02 41.81 42.36 1.32
Jul 07 42.02 41.90 42.15 0.60
Jul 08 42.23 42.04 42.53 1.16
Jul 09 42.02 41.76 42.12 0.86
Jul 10 42.25 41.91 42.57 1.57
Jul 11 42.38 42.28 42.52 0.57
Jul 12 42.34 42.14 42.65 1.22
Jul 13 42.09 41.81 42.35 1.29
Jul 14 41.91 41.77 42.16 0.95
Jul 15 42.01 41.92 42.13 0.51
Jul 16 41.70 41.56 41.97 1.00

GlaxoSmithKline Daily Price Targets


GlaxoSmithKline Stock Forecast 06-17-2025.

Forecast target price for 06-17-2025: $41.38.
Positive dynamics for GlaxoSmithKline shares will prevail with possible volatility of 0.659%.
Pessimistic target level: 41.20
Optimistic target level: 41.47

GlaxoSmithKline Stock Forecast 06-18-2025.

Forecast target price for 06-18-2025: $41.50.
Positive dynamics for GlaxoSmithKline shares will prevail with possible volatility of 1.175%.
Pessimistic target level: 41.18
Optimistic target level: 41.67

GlaxoSmithKline Stock Forecast 06-19-2025.

Forecast target price for 06-19-2025: $41.22.
Negative dynamics for GlaxoSmithKline shares will prevail with possible volatility of 1.043%.
Pessimistic target level: 41.09
Optimistic target level: 41.52

GlaxoSmithKline Stock Forecast 06-20-2025.

Forecast target price for 06-20-2025: $41.40.
Positive dynamics for GlaxoSmithKline shares will prevail with possible volatility of 0.985%.
Pessimistic target level: 41.20
Optimistic target level: 41.61

GlaxoSmithKline Stock Forecast 06-21-2025.

Forecast target price for 06-21-2025: $41.24.
Negative dynamics for GlaxoSmithKline shares will prevail with possible volatility of 1.033%.
Pessimistic target level: 41.09
Optimistic target level: 41.52

GlaxoSmithKline Stock Forecast 06-22-2025.

Forecast target price for 06-22-2025: $41.42.
Positive dynamics for GlaxoSmithKline shares will prevail with possible volatility of 0.967%.
Pessimistic target level: 41.14
Optimistic target level: 41.54

GSK (GSK) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jul. 40.80 39.91 41.46 3.72
Jul. 41.90 41.52 42.54 2.39
Aug. 41.67 41.05 42.21 2.75
Oct. 42.15 41.13 43.04 4.44
Oct. 41.55 40.63 42.40 4.17
Dec. 41.09 40.63 41.93 3.09
Dec. 41.89 41.10 42.22 2.65

GlaxoSmithKline forecast for this year


GlaxoSmithKline Stock Prediction for Jul 2025

An downtrend is forecast for this month with an optimal target price of $40.7961. Pessimistic: $39.91. Optimistic: $41.46


GlaxoSmithKline Stock Prediction for Jul 2025

An uptrend is forecast for this month with an optimal target price of $41.8976. Pessimistic: $41.52. Optimistic: $42.54


GlaxoSmithKline Stock Prediction for Aug 2025

An downtrend is forecast for this month with an optimal target price of $41.6714. Pessimistic: $41.05. Optimistic: $42.21


GlaxoSmithKline Stock Prediction for Oct 2025

An uptrend is forecast for this month with an optimal target price of $42.1464. Pessimistic: $41.13. Optimistic: $43.04


GlaxoSmithKline Stock Prediction for Oct 2025

An downtrend is forecast for this month with an optimal target price of $41.5522. Pessimistic: $40.63. Optimistic: $42.40


GlaxoSmithKline Stock Prediction for Dec 2025

An downtrend is forecast for this month with an optimal target price of $41.0909. Pessimistic: $40.63. Optimistic: $41.93


GlaxoSmithKline Stock Prediction for Dec 2025

An uptrend is forecast for this month with an optimal target price of $41.8922. Pessimistic: $41.10. Optimistic: $42.22



GlaxoSmithKline (GSK) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 41.39 41.09 42.21 2.65
Mar 41.22 40.57 41.82 2.99
Mar 42.27 41.46 42.89 3.34
May 41.78 40.93 42.16 2.91
May 41.02 40.63 41.43 1.93
Jul 40.72 40.29 41.27 2.40
Jul 40.68 40.22 41.36 2.74
Aug 41.90 41.53 42.22 1.64
Oct 42.08 41.68 42.79 2.60
Oct 41.81 40.82 42.68 4.38
Dec 42.72 41.94 43.17 2.85
Dec 43.97 43.00 44.43 3.21

GlaxoSmithKline (GSK) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 44.30 43.37 45.16 3.97
Mar 43.86 43.02 44.34 3.00
Mar 44.49 43.46 44.78 2.95
May 43.94 43.31 45.00 3.75
May 44.06 43.16 45.10 4.31
Jul 44.68 43.92 45.71 3.93
Jul 45.70 45.26 46.34 2.34
Aug 46.56 45.46 47.67 4.63
Oct 46.83 46.37 47.73 2.86
Oct 47.50 46.82 48.59 3.64
Dec 47.55 46.59 48.67 4.28
Dec 47.87 47.16 48.88 3.53

GlaxoSmithKline information and performance

GlaxoSmithKline Address

980 GREAT WEST ROAD, BRENTFORD MIDDLESEX, GB

Market Capitalization: 81 111 597 000 $

Market capitalization of the GlaxoSmithKline plc is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of GSK shares in the company outstanding by the market price of one share.

EBITDA: 8 654 000 000 $

EBITDA of GlaxoSmithKline is earnings before interest, income tax and depreciation of assets.

PE Ratio: 19.42

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 0.389

Price/earnings to growth

DPS: 0.62

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: 0.04

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 2.06

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 0.547
Quarterly Revenue Growth YOY: 0.021
Trailing PE: 19.42

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 8.87

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 2.303

Enterprise Value (EV) /Revenue

EV To EBITDA: 9.44

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 2027790000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

GlaxoSmithKline (GSK) stock dividend

GlaxoSmithKline last paid dividends on 05/16/2025. The next scheduled payment will be on 07/10/2025. The amount of dividends is $0.62 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.

Last Split Factor:

Last Split Date: 01/01/1970

Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.

For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.

FAQ (Frequently Asked Questions about GlaxoSmithKline Stock)

Should I Buy GlaxoSmithKline Shares in 2025 year?

The maximum forecasted share price for next year is $43.97, which is $3.11 higher than the current stock price. By investing in GlaxoSmithKline shares today for a one-year period, you could achieve a profit of 7.60%. With an investment horizon of up to two years, the target share price is $47.87. resulting in a profit of 17.17% ($7.01 per share).

Does GlaxoSmithKline pay dividends?

No, it does not

Which economic sector do GlaxoSmithKline's shares belong to?

GlaxoSmithKline's shares belong to the "Healthcare" sector of economic.

Which other securities belong to the same sector as GlaxoSmithKline's shares?

You can view all the stocks that are part of the same sector as GlaxoSmithKline's shares in the Healthcare section.


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.